My PCR
Create Account
Logo PCR

17 May 2022

Stents, scaffolds and DCB

Sirolimus coated balloon and coronary artery disease: expanding the treatment indications

Sponsored by Concept Medical Inc.

Anchorperson: P. Serruys
Moderator: A. Latib
SHOW MORE

Summary

Through a case presentation, as well as upcoming studies and rationale for the Food and Drug Administration, the aim of this EuroPCR 2022 session is to help you answer the following questions: how can the use of a sirolimus-coated DCB be expanded in new and challenging treatment indications? Why is sirolimus-coated balloon the ideal choice in native vessel disease treatment? What does the future hold for sirolimus-coated balloons?

Learning Objectives

  • To understand how to widen the use of a sirolimus DCB in new and challenging treatment indications
  • To know why sirolimus coated balloon is the ideal choice in native vessel disease treatment through a case presentation
  • To know what the future has in store for sirolimus coated balloons - upcoming studies and rationale for the Food and Drug Administration
Related Content
Share your work at PCR-CIT China Chengdu Valves 2025 How to avoid using a new balloon for trapping? Preventing distal particles embolization after DCB angioplasty
Recommended for you
AICT-AsiaPCR: what's in store this year? What's the best way to reduce the cost of your #AictPCR badge? AICT-AsiaPCR: Call for Submissions is now open